• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么保乳治疗后局部复发在年轻患者中更常见?

Why are local recurrences after breast-conserving therapy more frequent in younger patients?

作者信息

Kurtz J M, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier J M

机构信息

Department of Anatomic Pathology, Marseille Cancer Institute, France.

出版信息

J Clin Oncol. 1990 Apr;8(4):591-8. doi: 10.1200/JCO.1990.8.4.591.

DOI:10.1200/JCO.1990.8.4.591
PMID:2313329
Abstract

The influence of patient age on risk of recurrence in the breast was retrospectively studied in 496 stage I-II invasive ductal carcinomas treated by macroscopically complete primary tumor excision followed by radiotherapy. With a median follow-up of 71 months, local recurrence occurred in 13 of 62 (21%) patients younger than 40 years, compared with 48 of 434 (11%) older patients (P less than .025). Cox multivariate analysis of 18 parameters identified four that significantly determined risk: major lymphocytic stromal reaction (MCR), unsatisfactory resection margins, increasing histologic grade, and extensive intraductal cancer (DCIS) within the primary tumor. Compared with older patients, those younger than 40 years had tumors that more often exhibited MCR (36% v 20%, P less than .01), histologic grade 3 (42% v 28%, P less than .025), and very extensive DCIS (21% v 6%, P less than .001). The status of resection margins did not differ significantly between younger and older patients. Restriction of Cox analysis to patients younger than 40 indicated that risk was adequately described by MCR and percentage of DCIS, without consideration of grade or margins. For patients younger than 40, local failure occurred in four of five (80%) tumors with both MCR and more than 50% DCIS, in eight of 25 (32%) with either, and one of 32 (3.1%) with neither of these morphologic features. This study suggests that the higher local failure risk observed in patients younger than 40 years reflects the greater prevalence of certain morphologic characteristics in breast cancers in younger patients. Age itself does not appear to be an independent determinate of risk.

摘要

对496例接受了肉眼可见的原发性肿瘤完整切除并随后进行放疗的I-II期浸润性导管癌患者进行回顾性研究,以探讨患者年龄对乳腺癌复发风险的影响。中位随访时间为71个月,62例40岁以下患者中有13例(21%)发生局部复发,而434例年龄较大的患者中有48例(11%)发生局部复发(P<0.025)。对18个参数进行Cox多因素分析,确定了4个显著决定风险的因素:主要淋巴细胞间质反应(MCR)、切除边缘不理想、组织学分级增加以及原发性肿瘤内广泛的导管内癌(DCIS)。与年龄较大的患者相比,40岁以下的患者肿瘤更常表现出MCR(36%对20%,P<0.01)、组织学3级(42%对28%,P<0.025)和非常广泛的DCIS(21%对6%,P<0.001)。年轻患者和老年患者的切除边缘状态没有显著差异。将Cox分析限制在40岁以下的患者中表明,MCR和DCIS百分比能够充分描述风险,而无需考虑分级或边缘情况。对于40岁以下的患者,在同时具有MCR和超过50% DCIS的5个肿瘤中有4个(80%)发生局部失败,在具有其中任何一个特征的25个肿瘤中有8个(32%)发生局部失败,在不具有这两种形态学特征的32个肿瘤中有1个(3.1%)发生局部失败。本研究表明,40岁以下患者中观察到的较高局部失败风险反映了年轻患者乳腺癌中某些形态学特征的更高发生率。年龄本身似乎不是风险的独立决定因素。

相似文献

1
Why are local recurrences after breast-conserving therapy more frequent in younger patients?为什么保乳治疗后局部复发在年轻患者中更常见?
J Clin Oncol. 1990 Apr;8(4):591-8. doi: 10.1200/JCO.1990.8.4.591.
2
Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.接受保乳治疗的绝经前和绝经后导管癌患者乳腺复发的危险因素。
Cancer. 1990 Apr 15;65(8):1867-78. doi: 10.1002/1097-0142(19900415)65:8<1867::aid-cncr2820650833>3.0.co;2-i.
3
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
4
Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.保乳手术中用于术中切缘评估的冰冻切片分析导致再次切除率和局部复发率较低。
Ann Surg Oncol. 2007 Oct;14(10):2953-60. doi: 10.1245/s10434-007-9437-1. Epub 2007 Aug 3.
5
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.导管原位癌保乳治疗后复发和转移的危险因素:欧洲癌症研究与治疗组织10853试验分析
J Clin Oncol. 2001 Apr 15;19(8):2263-71. doi: 10.1200/JCO.2001.19.8.2263.
6
Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.年轻对接受保乳治疗的导管原位癌患者预后的影响。
J Clin Oncol. 2000 Jan;18(2):296-306. doi: 10.1200/JCO.2000.18.2.296.
7
Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.保乳放疗后切缘阳性范围作为局部复发的预测指标
Radiat Oncol Investig. 1999;7(2):111-7. doi: 10.1002/(SICI)1520-6823(1999)7:2<111::AID-ROI7>3.0.CO;2-U.
8
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
9
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
10
Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.未经放疗的乳腺导管原位癌保守治疗后的局部复发:年龄的影响
Ann Surg Oncol. 2006 Jul;13(7):990-8. doi: 10.1245/ASO.2006.05.044. Epub 2006 May 22.

引用本文的文献

1
Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.年轻(<40 岁)对黎巴嫩乳腺癌患者肿瘤学结局的影响:一项匹配队列研究。
BMC Cancer. 2024 May 4;24(1):560. doi: 10.1186/s12885-024-11910-w.
2
Incidence and risk factors of lymph node metastasis in breast cancer patients without preoperative chemoradiotherapy and neoadjuvant therapy: analysis of SEER data.未接受术前放化疗和新辅助治疗的乳腺癌患者淋巴结转移的发生率及危险因素:监测、流行病学与最终结果(SEER)数据的分析
Gland Surg. 2023 Nov 24;12(11):1508-1524. doi: 10.21037/gs-23-258. Epub 2023 Nov 17.
3
What Is Known about Breast Cancer in Young Women?
关于年轻女性乳腺癌我们了解多少?
Cancers (Basel). 2023 Mar 22;15(6):1917. doi: 10.3390/cancers15061917.
4
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database.年轻女性乳腺癌表现出更具侵袭性的病理特征:来自阿根廷国家数据库的回顾性分析。
JCO Glob Oncol. 2020 Apr;6:639-646. doi: 10.1200/JGO.19.00228.
5
The association of young age with local recurrence in women with early-stage breast cancer after breast-conserving therapy: a meta-analysis.保乳治疗后早期乳腺癌女性中年龄与局部复发的相关性:一项荟萃分析。
Sci Rep. 2017 Sep 11;7(1):11058. doi: 10.1038/s41598-017-10729-9.
6
True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer.早期乳腺癌患者保乳手术后的真性局部复发预后较差。
Cureus. 2016 Mar 24;8(3):e541. doi: 10.7759/cureus.541.
7
Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.导管原位癌成分的存在及数量对浸润性乳腺癌预后的影响。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13304-13. eCollection 2015.
8
Guideline conformity treatment in young women with early-onset breast cancer in Germany.德国早期发病乳腺癌年轻女性的指南一致性治疗。
Breast Care (Basel). 2014 Oct;9(5):349-54. doi: 10.1159/000366435.
9
Unique aspects of caring for young breast cancer patients.照顾年轻乳腺癌患者的独特方面。
Curr Oncol Rep. 2015 Feb;17(2):1. doi: 10.1007/s11912-014-0425-x.
10
Breast cancer in young women: special considerations in multidisciplinary care.年轻女性乳腺癌:多学科护理中的特殊考虑。
J Multidiscip Healthc. 2014 Sep 29;7:419-29. doi: 10.2147/JMDH.S49994. eCollection 2014.